Autophagy inhibition improves sensitivity to the multi-kinase inhibitor regorafenib in preclinical mouse colon tumoroids
Colorectal cancer (CRC) remains the second leading cause of cancer-related deaths worldwide, with its incidence continuing to rise. Regorafenib, a multi-kinase inhibitor approved for palliative treatment, has been shown to extend survival in patients with metastatic CRC (mCRC) who have failed standa...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2025-07-01
|
| Seri Bilgileri: | Frontiers in Cell and Developmental Biology |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/articles/10.3389/fcell.2025.1631116/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|